Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Chinese scientists have developed a breakthrough process that significantly improves the efficiency and environmental friendliness of beta-blocker production—with a focus on the widely used ...

Beta-blockers are one of the first-line medications often prescribed for migraine prevention. Discover the benefits, side effects, and efficacy of this 50-year-old preventive.

Population-adjusted ITCswithout a common control exhibited significantly greater mean improvements in MG-ADL scores favouring nipocalimab over other FcRn blockers at Weeks 8 d to 24 versus one ...

Indirect treatment comparisons (ITCs) were conducted to compare efficacy onset using 1-week timepoint, and for consistency and sustained disease control, comparisons were conducted for multiple ...

Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...

Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment ...

BEERSE, BELGIUM , June 23, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company today announced new data from an indirect treatment comparison (ITC) that showed ...

Johnson & Johnson (NYSE: JNJ) today announced new data from an indirect treatment comparison (ITC) that showed consistent and sustained disease control with IMAAVY™ (nipocalimab-aahu) versus other ...